Medicine
Mupirocin 2% cream
Mupirocin 2% cream is a generic prescription medicine for topical use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Mupirocin
- Brand
- Sold under the generic name
- Strength
- 2%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube, 15 g, 30 g and 18 more
- Manufacturers
- Alembic PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaSun Pharmaceutical IndustriesIndiaViona PharmaceuticalsIndiaZydus LifesciencesIndiaAmneal Pharmaceuticals NYEncube EthicalsNorthStar RxSportpharmRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D06AX09 Mupirocin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 January 2013
- Identifiers
- RxCUI 311877DailyMed set ID e250adda-52a5-486f-a43d-2cc486dbe2a8, 6f1c0789-4a3b-473a-96d6-0c479ee32d36, acd6e23e-d83f-4ed8-9c50-467ed422a8c4 +8NDC 85766-204, 16714-055, 68462-564 +8Application ANDA213076, ANDA207116, ANDA201587 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 15 g in 1 tube | 46708-624-15 | Alembic PharmaceuticalsIndia | 18 March 2025 |
| 1 tube in 1 carton / 30 g in 1 tube | 46708-624-30 | Alembic PharmaceuticalsIndia | 18 March 2025 |
| 1 tube in 1 carton / 15 g in 1 tube | 62332-624-15 | Alembic PharmaceuticalsIndia | 1 December 2021 |
| 1 tube in 1 carton / 30 g in 1 tube | 62332-624-30 | Alembic PharmaceuticalsIndia | 1 December 2021 |
| 15 g in 1 tube | 68462-564-17 | Glenmark PharmaceuticalsIndia | 24 January 2013 |
| 30 g in 1 tube | 68462-564-35 | Glenmark PharmaceuticalsIndia | 24 January 2013 |
| 1 tube in 1 carton / 15 g in 1 tube | 51672-1370-1 | Sun Pharmaceutical IndustriesIndia | 27 April 2020 |
| 1 tube in 1 carton / 30 g in 1 tube | 51672-1370-2 | Sun Pharmaceutical IndustriesIndia | 27 April 2020 |
| 1 tube in 1 carton / 15 g in 1 tube | 72578-130-01 | Viona PharmaceuticalsIndia | 10 October 2026 |
| 1 tube in 1 carton / 30 g in 1 tube | 72578-130-06 | Viona PharmaceuticalsIndia | 10 October 2026 |
| 1 tube in 1 carton / 15 g in 1 tube | 70771-1981-1 | Zydus LifesciencesIndia | 10 October 2026 |
| 1 tube in 1 carton / 30 g in 1 tube | 70771-1981-2 | Zydus LifesciencesIndia | 10 October 2026 |
| 1 tube in 1 carton / 30 g in 1 tube | 69238-2029-3 | Amneal Pharmaceuticals NY | 17 November 2022 |
| 1 tube in 1 carton / 15 g in 1 tube | 69238-2029-5 | Amneal Pharmaceuticals NY | 17 November 2022 |
| 1 tube in 1 carton / 15 g in 1 tube | 21922-029-04 | Encube Ethicals | 2 September 2021 |
| 1 tube in 1 carton / 30 g in 1 tube | 21922-029-05 | Encube Ethicals | 2 September 2021 |
| 1 tube in 1 carton / 15 g in 1 tube | 16714-055-01 | Northstar RX | 25 November 2020 |
| 1 tube in 1 carton / 30 g in 1 tube | 16714-055-02 | Northstar RX | 25 November 2020 |
| 1 tube in 1 carton / 30 g in 1 tube | 70518-3774-0 | Remedyrepack | 22 June 2023 |
| 1 tube in 1 carton / 15 g in 1 tube | 85766-204-15 | Sportpharm | 4 May 2026 |
| 1 tube in 1 carton / 30 g in 1 tube | 85766-204-30 | Sportpharm | 4 May 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 31 December 1987 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Mupirocin 2% cream.
Other strengths and forms of Mupirocin
Clinical summary
Mupirocin is an RNA synthetase inhibitor antibacterial. It is available as ointment and cream for topical use. MedsAcross supplies Mupirocin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MupirocinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mupirocin prescribing information (Viona Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Mupirocin 2% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.